Adenosine Discussion for the Treatment of COVID-19, ARDS & MERS

Dr. Nick Gravenstein  and Cyndi Garvan, PhD   with the University of Florida present the use of adenosine for the treatment of ARDS caused by COVID-19. Led by Dr. Bruce Spiess, the “Arctic Team at University of Florida investigates adenosine, a ubiquitous molecule with all kinds of important impacts. It actually can interfere with some viral entry into cells. Normally it’s used to treat cardiac arrhythmias (intravenously) but the team from Florida think there could be a potential COVID-19 repurpose use case for the already approved drug.  For example it has shown antiviral qualities. Watch the event sponsored by Steve Kirsch and the COVID-19 Early Treatment Fund (CETF).

Responses

This site uses Akismet to reduce spam. Learn how your comment data is processed.